Infectious disease news covering outbreaks, vaccines, antimicrobial resistance, and global health surveillance.
This commentary argues that armed conflicts in the Democratic Republic of the Congo, Sudan, and Yemen are accelerating the spread of diseases like Ebola by creating overcrowded displacement camps and disrupting healthcare access. It contends that international humanitarian law must be reinforced through practical negotiations with all conflict actors to protect health infrastructure.
Illinois reports 277 cyclosporiasis cases as of July 17, with 23 hospitalizations and no deaths. Nationwide, 1,645 cases have been confirmed across 34 states since May, with 141 hospitalizations. Virginia has reported 37 cases but no outbreak. The source remains under investigation.
This commentary argues that dengue fever poses hidden cardiac risks, including myocarditis and arrhythmias, which are often overlooked. It contends that doctors should consider cardiac involvement in dengue patients, especially those with severe symptoms, and calls for greater awareness of the disease's multisystemic nature.
The Joint Committee on Vaccination and Immunisation recommended offering the meningitis B vaccine to all UK teenagers around age 15 on the NHS, with catch-up programs for those who missed it. The move follows meningitis outbreaks, including one in Kent earlier this year that left two teenagers dead.
This commentary argues that India's achievement of 95% measles vaccine coverage is a significant public health success, highlighting the country's progress in reducing unvaccinated children. It contends that despite high coverage, measles outbreaks persist due to the disease's high contagiousness and the need for near-universal immunization to prevent spread.
Gates Medical Research Institute partnered with Serum Institute of India to manufacture the M72/AS01E tuberculosis vaccine candidate. SII will invest over $100 million to strengthen manufacturing readiness. GSK will supply the AS01E adjuvant. The vaccine is in Phase 3 trials with 20,000 participants.
Northern Ireland will begin offering meningitis B vaccines to Year 14 students and under-25s starting university from July 31, 2026. The two-dose schedule follows a deadly outbreak in England earlier this year.
Two new measles cases were reported in Chester County, Pennsylvania, bringing its total to six since the outbreak began. Pennsylvania has seen 110 cases this year, the largest in three decades, with 19 hospitalizations. None of the patients were fully vaccinated.
A rollout date has been agreed for the MenB vaccine for university students in Northern Ireland, targeting those heading to university in September. The vaccine protects against meningococcal group B disease.
A reality star shared grim details after contracting cyclosporiasis, a parasite causing severe gastrointestinal distress. The infection has been reported in 34 U.S. states amid a nationwide outbreak.